Clinical Diagnosis and Prognosis of Urologic Oncology

Dear Colleagues,

This Special Issue aims to explore the current landscape and future directions in the clinical diagnosis and prognosis of urologic cancers, including prostate, bladder, kidney, and testicular malignancies. Advances in imaging, biomarkers, genomic profiling, and artificial intelligence are transforming early detection and risk stratification, enabling more precise and individualized approaches to care. Yet, significant challenges remain in integrating these innovations into routine clinical practice, especially in diverse healthcare settings.

We welcome original research, reviews, and clinical guidelines that address novel diagnostic techniques, prognostic models, and clinical decision-making tools. Topics of interest include, but are not limited to, liquid biopsies, radiogenomics, molecular risk classifiers, nomograms, and machine learning applications. Submissions focusing on validation of diagnostic/prognostic tools in real-world settings, comparative effectiveness, and impact on patient outcomes are especially encouraged.

The goal of this Special Issue is to provide a comprehensive overview of the evolving tools shaping the future of urologic oncology and to foster discussion on how these tools can be optimized and implemented to improve clinical outcomes. Multidisciplinary perspectives that integrate urology, oncology, radiology, pathology, and data science are highly valued.

Dr. Juan Gómez Rivas
Dr. Jesús Moreno Sierra
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.